|
GSK, FivePrime partner to discover new asthma and COPD treatments
MedCity News Under the new partnership, the companies aim to find new ways to treat asthma and chronic obstructive pulmonary disorder, or COPD. Over the next four years, privately held FivePrime stands to gain up to $30 million from the new deal in the form of … Five Prime strikes deal with GSK for asthma drug Five Prime, GSK sign strategic drug discovery alliance Five Prime Therapeutics Announces Second Strategic Alliance With GlaxoSmithKline |
View full post on asthma – Google News